Latest News about VRTX
Recent news which mentions VRTX
A Look Into Vertex Pharmaceuticals Inc's Price Over Earnings
January 23, 2024
From Benzinga
1 Setback and 1 Opportunity for CRISPR Therapeutics Stock
January 23, 2024
From Motley Fool
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
January 22, 2024
From Benzinga
Here's How Much $1000 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth Today
January 22, 2024
From Benzinga
If You Invested $10,000 in Vertex Pharmaceuticals in 2018, This Is How Much You Would Have Today
January 22, 2024
From Motley Fool
2 Smart Growth Stocks to Buy Hand Over Fist in 2024
January 21, 2024
From Motley Fool
3 Unstoppable Growth Stocks That Can Make You Richer in 2024
January 20, 2024
From Motley Fool
These 2 Phenomenal Growth Stocks Can Make You Richer in 2024
January 20, 2024
From Motley Fool
3 High-Flying Stocks That Could Soar Even More in 2024
January 20, 2024
From Motley Fool
Gene Therapy For Beta-Thalassemia: CRISPR Therapeutics/Vertex's Casgevy Secures FDA Nod Ahead of Schedule
January 17, 2024
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
January 16, 2024
From Benzinga
Here's Why CRISPR Therapeutics Stock Rose 54% Last Year
January 15, 2024
From Motley Fool
Down 88%, Could Editas Medicine Be a Good Investment Now?
January 15, 2024
From Motley Fool
My 3 Highest-Conviction Growth Stocks to Buy in 2024
January 14, 2024
From Motley Fool
3 Growth Stocks to Buy That Could Be Massive Long-Term Winners
January 14, 2024
From Motley Fool
3 Unstoppable Stocks to Buy in 2024
January 13, 2024
From Motley Fool
Cathie Wood Goes Bargain Hunting: 3 Stocks She Bought This Week
January 13, 2024
From Motley Fool
Uber, Abbott Laboratories, Vertex Pharmaceuticals And More On CNBC's 'Final Trades'
January 12, 2024
From Benzinga
3 Stocks to Buy in the Booming Field of Gene Editing
January 11, 2024
From InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
January 10, 2024
From Benzinga
2 Red Flags for Bluebird Bio Stock
January 10, 2024
From Motley Fool
These 3 Stocks Have Beaten the S&P Average Return for Years and Are Likely to Continue That Trend
January 10, 2024
From Motley Fool
A Look Into Vertex Pharmaceuticals Inc's Price Over Earnings
January 09, 2024
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.